Robert M Davis
CIK 1363076 · Chairman, CEO & President · last filed 2026-05-11
Robert M Davis is a Chairman, CEO & President who has filed 72 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider was granted $200.0K of DUK on May 11, 2026. Across all open-market trades the lifetime net is −$140.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $70.7M across reported positions. 36 SEC filings were submitted jointly with Merck & Co., Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MRK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
P.O. BOX 2000
RAHWAY, NJ 07065
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DUK | Director | 14,262 | $121.47 | $1.73M | $0 | 8 | 2026-05-11 |
| MRK | Chairman, CEO & President | 450,350 | $145.95 | $65.73M | -$123.52M | 30 | 2026-05-07 |
| DUKH | Director | 614 | $23.16 | $14.2K | $0 | 2 | 2018-05-07 |
| BAX | Corporate Vice President | 125,899 | $25.28 | $3.18M | -$16.95M | 24 | 2014-03-06 |
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | DUK | Grant (A) | +1,602 | $200.0K | EDGAR |
| 2026-05-07 | MRK | Grant (A) | — | $0 | EDGAR |
| 2026-05-01 | MRK | Mixed | +6,749 | $742.6K | EDGAR |
| 2026-02-06 | MRK | Sell (S) | −47,434 | -$5.60M | EDGAR |
| 2026-02-04 | MRK | Notice (144) | −47,434 | -$5.60M | EDGAR |
| 2026-01-28 | MRK | Grant (A) | +47,434 | $5.09M | EDGAR |
| 2025-05-05 | DUK | Grant (A) | +1,607 | $195.0K | EDGAR |
| 2025-05-01 | MRK | Grant (A) | — | $0 | EDGAR |
| 2025-01-29 | MRK | Grant (A) | +95,275 | $9.33M | EDGAR |
| 2024-05-13 | DUK | Grant (A) | +1,698 | $175.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.